Perineural dexamethasone: neurotoxicity or neuroprotection? A systematic review of preclinical evidence
- PMID: 40770367
- PMCID: PMC12329900
- DOI: 10.1186/s44158-025-00271-w
Perineural dexamethasone: neurotoxicity or neuroprotection? A systematic review of preclinical evidence
Abstract
Background: Perineural dexamethasone is widely used as an adjuvant to local anesthetics in regional anesthesia to prolong analgesia. However, concerns persist regarding its potential neurotoxic effects, particularly when administered perineurally. This systematic review aims to synthesize preclinical evidence evaluating the neurotoxicity or neuroprotective properties of perineural dexamethasone.
Methods: A systematic search of PubMed, CENTRAL, Scopus, and Embase was conducted through May 22, 2025. Eligible studies included in vivo or in vitro preclinical models assessing the neurotoxic or neuroprotective effects of perineural dexamethasone compared to control conditions. Risk of bias was assessed using the SYRCLE tool for in vivo studies and a narrative evaluation for in vitro studies. A total of 14 studies (11 in vivo, 3 in vitro) met inclusion criteria.
Results: In vitro studies showed that dexamethasone alone was not neurotoxic at clinically relevant doses but could enhance cytotoxicity when combined with local anesthetics at higher concentrations. In vivo models generally demonstrated no significant long-term nerve inflammation, degeneration or demyelination, with some early protective effects observed in perineural dexamethasone groups. However, all in vivo studies were rated at high risk of bias. In nerve injury models, dexamethasone reduced apoptotic and inflammatory markers when administered immediately post-injury, with limited effect when delayed.
Conclusions: Preclinical evidence supports the general safety of low-dose, preservative-free perineural dexamethasone. Nonetheless, high-dose use, additives, and application in patients with neuropathies may pose risks. Given the high risk of bias in existing studies and minimal added benefit over systemic administration, clinical caution is advised.
Keywords: Dexamethasone; Neuroprotective; Neurotoxic; Perineural; Safety.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
References
-
- Williams BA, Schott NJ, Mangione MP, Ibinson JW (2014) Perineural dexamethasone and multimodal perineural analgesia: how much is too much? Anesth Analg 118(5):912–914. 10.1213/ANE.0000000000000203 - PubMed
-
- Sehmbi H, Brull R, Ceballos KR et al (2021) Perineural and intravenous dexamethasone and dexmedetomidine: network meta-analysis of adjunctive effects on supraclavicular brachial plexus block. Anaesthesia 76(7):974–990. 10.1111/anae.15288 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous